Quick Answer
Sonoma Pharmaceuticals, Inc. reported Research And Development Expense of $1.81 million for the year ending 2025.
- Sonoma Pharmaceuticals, Inc. showed a decrease of -3.0% in Research And Development Expense from 2024 to 2025.
- This data is from Sonoma Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), Sonoma Pharmaceuticals, Inc.'s Research And Development Expense has declined by 11.3%.
- Historical annual values: Fiscal year 2025: $1.81 million | Fiscal year 2024: $1.87 million | Fiscal year 2023: $207.0 thousand | Fiscal year 2022: $125.0 thousand | Fiscal year 2021: $555.0 thousand | Fiscal year 2020: $1.34 million | Fiscal year 2019: $1.52 million | Fiscal year 2018: $1.58 million | Fiscal year 2017: $1.58 million | Fiscal year 2016: $1.81 million | Fiscal year 2015: $1.53 million | Fiscal year 2014: $2.89 million | Fiscal year 2013: $2.22 million | Fiscal year 2012: $1.98 million | Fiscal year 2011: $2.05 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: